Last update 14 Dec 2024
SPH3348
Last update 14 Dec 2024
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms SPH-3348 |
Target |
Mechanism c-Met inhibitors(Hepatocyte growth factor receptor inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
RegulationSpecial Review Project (CN) |
Login to view timeline
Related
3
Clinical Trials associated with SPH3348SPH3348片在中国健康受试者中单中心、随机、开放、单次给药、两周期、两序列交叉设计的食物影响研究
[Translation] A single-center, randomized, open-label, single-dose, two-period, two-sequence crossover design study on the food effect of SPH3348 tablets in Chinese healthy subjects
SPH3348 Tablets in a Single-center, Randomized, Open-label, Single-dose, Two-period, Two-sequence Crossover Design Food Effect Study in Healthy Chinese Subjects
SPH3348片单药及联用奥希替尼治疗中国c-Met异常的晚期实体瘤患者的I期临床试验
[Translation] Phase I clinical trial of SPH3348 tablets alone and in combination with osimertinib in Chinese patients with advanced solid tumors with c-Met abnormalities
100 Clinical Results associated with SPH3348
Login to view more data
100 Translational Medicine associated with SPH3348
Login to view more data
100 Patents (Medical) associated with SPH3348
Login to view more data
100 Deals associated with SPH3348
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Neoplasms | Phase 1 | CN | 15 Jul 2022 | |
| Neoplasms | Phase 1 | CN | 15 Jul 2022 | |
| Advanced Malignant Solid Neoplasm | Phase 1 | CN | 03 Jun 2020 | |
| Advanced Malignant Solid Neoplasm | Phase 1 | CN | 03 Jun 2020 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free